RenBio’s $24 Million Series A Financing and Covid-19 Antibody Agreement

Morgan Lewis represented RenBio Inc. in the transaction.RenBio Inc. closed a $24 million Series A investment and a license agreement with Columbia University for exclusive worldwide development…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now